Chronic XXXX : Reduction of Medication Use After Pelvic Floor Physical Therapy with an Internal Myofascial Trigger Point Wand.

@entity1 @entity676 @entity2371 @entity2798
UNASSIGNED: This study documents the @entity2798 in medication use in @entity1 with refractory chronic @entity2371 utilizing a protocol of pelvic floor myofascial trigger point release with an FDA approved internal trigger point wand and paradoxical relaxation therapy. Self-referred @entity1 were enrolled in a 6-day training clinic from October, 2008 to May, 2011 and followed the protocol for 6  months. Medication usage and symptom scores on a 1-10 scale (10  =  most severe) were collected at baseline, @entity676  months. All changes in medication use were at the @entity1 's discretion. Changes in medication use were assessed by McNemar's test in both complete case and modified intention to treat (mITT) analyses. 374 out of 396 @entity1 met inclusion criteria; 79.7  % were male, median age of 43  years and median symptom duration of 5  years. In the complete case analysis, the percent of @entity1 using medications at baseline was 63.6  %. After 6  months of treatment the percentage was 40.1  %, a 36.9  % reduction (p  <  0.001). In the mITT analysis, there was a 22.7  % overall reduction from baseline (p  <  0.001). Medication cessation at 6  months was significantly associated with a reduction in total symptoms (p  =  0.03).
